facebook
Subscribe50$/product give away!


Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

EVARREST- fibrinogen human and human thrombin patch


Patient Information

  • Advise patients to consult their physician if they experience chest pain, shortness of breath, difficulty speaking or swallowing, leg tenderness or swelling, or other symptoms of thromboembolism.
  • Inform patients that EVARRESTmay carry a risk of transmitting infectious agents, e.g., viruses such as hepatitis A and parvovirus B19 and theoretically the CJD agent. Instruct patients to consult their physician if symptoms of B19 virus infection (fever, drowsiness, and chills, followed two weeks later by a rash and joint pain) or hepatitis A (several days to weeks of poor appetite, fatigue and low-grade fever followed by nausea, vomiting and abdominal pain, dark urine, yellowed complexion) appear.

Distributed by:
Ethicon, Inc.
Route 22 West, PO Box 151
Somerville, NJ 08876-0151
USA

Manufactured by:
Omrix Biopharmaceuticals Ltd.
14 Einstein Street
Weizmann Science Park
Nes-Ziona, Israel

US License No. 1879

2016 Ethicon, Inc.

Art. No. 80XZ24Z3S5



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources
2017 © Copyright PharmacyHQ.com. Questions?
Please contact: pharmacyhq.mail@gmail.com